|
|
|
|
LEADER |
03086nam a22003255i 4500 |
001 |
000280898 |
005 |
20211108155704.0 |
007 |
cr nn 008mamaa |
008 |
100301s2009 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781603270885
|
024 |
7 |
|
|a 10.1007/978-1-60327-088-5
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response /
|c edited by Federico Innocenti.
|
250 |
|
|
|a 1st ed. 2009.
|
260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2009.
|
300 |
|
|
|a XIV, 378 p. 53 illus., 3 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Cancer Drug Discovery and Development,
|
505 |
0 |
|
|a Genomic Experimental Approaches in Oncology -- Toward the Realization of the Promise of Microarrays in Oncology -- Cell-Based Models to Identify Genetic Variants Contributing to Anticancer Drug Response -- Proteomic Analysis in Cancer Patients -- MicroRNAs and Discovery of New Targets -- Pharmacogenomics of the National Cancer Institute’s 60-Tumor Cell Panel -- Use of Single-Nucleotide Polymorphism Array for Tumor Aberrations in Gene Copy Numbers -- Pharmacogenomics of Toxicity and Response of Chemotherapy -- Concordance Between Tumor and Germline DNA -- Epidermal Growth Factor Receptor Mutations and Sensitivity to Selective Kinase Inhibitors in Human Lung Cancer -- BCR-ABL Mutations and Imatinib Resistance in Chronic Myeloid Leukemia Patients -- Role of Thymidylate Synthase Gene Variations in Colorectal Cancer Patients -- Thiopurines in the Treatment of Childhood Acute Lymphoblastic Leukemia and Genetic Variants of the Thiopurine S-Methyltransferase Gene -- Impact of Polymorphisms on the Clinical Outcomes of Monoclonal Antibody Therapy Against Hematologic Malignancies -- DNA Repair and Mitotic Checkpoint Genes as Potential Predictors of Chemotherapy Response in Non-Small-Cell Lung Cancer -- Dihydropyrimidine Dehydrogenase (Dpyd) Gene Polymorphism: Portrait of a Serial Killer -- Impact of UDP-Glucuronosyltransferase 1A Haplotypes on Irinotecan Treatment -- Microarray Profiling in Breast Cancer Patients -- Role of the Folate-Pathway and the Thymidylate Synthase Genes in Pediatric Acute Lymphoblastic Leukemia Treatment Response -- Pharmacogenomics in Clinical Drug Development in Oncology -- Pharmacogenomics in Drug Development: A Pharmaceutical Industry Perspective -- Identification of Pharmacogenomic Biomarker Classifiers in Cancer Drug Development -- Toxicogenomics Application to Oncology Drug Development -- Strategies to Identify Pharmacogenomic Biomarkers: Candidate Gene, Pathway-Based, and Genome-Wide Approaches.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Human genetics.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Human Genetics.
|
700 |
1 |
|
|a Innocenti, Federico.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|